The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Molecular Insight Pharmaceuticals competitive analysis

Loading summary...

Latest patents of Molecular Insight Pharmaceuticals opposed by its competitors

Explore Molecular Insight Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3699162
Jun 29, 2022Heterodimers Of Glutamic Acid1
EP3335736
Dec 30, 2020Heterodimers Of Glutamic Acid3

Latest PTAB cases involving Molecular Insight Pharmaceuticals

Discover the latest PTAB cases involving Molecular Insight Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 13, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Molecular Insight Pharmaceuticals

PGR2021-00048Feb 4, 2021ADVANCED ACCELERATOR APPLICATIONS USAMOLECULAR INSIGHT PHARMACEUTICALSTerminated-Settled

Peer Comparison New

IP litigation analysis comparing Molecular Insight Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MOLECULAR INSIGHT PHARMACEUTICALS - 4 - 1
ADVANCED ACCELERATOR APPLICATIONS USA - - 1 -
DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS UNIVERSITAT HEIDELBERG1 - - -
LEWIS SILKIN2 - - -